Published in Antiviral Res on December 01, 2001
Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. Antimicrob Agents Chemother (2003) 1.21
Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein. PLoS One (2009) 1.10
Antiviral strategies for pandemic and seasonal influenza. Viruses (2010) 0.95
Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors. Clin Diagn Lab Immunol (2004) 0.87
Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181. J Antimicrob Chemother (2010) 0.84
Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections. Front Microbiol (2016) 0.78
Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science (1972) 7.74
Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc Natl Acad Sci U S A (1973) 4.36
Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. J Med Chem (1972) 4.12
In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob Agents Chemother (1973) 4.04
Longitudinal studies of Aedes aegypti (Diptera: Culicidae) in Thailand and Puerto Rico: blood feeding frequency. J Med Entomol (2000) 3.59
Use of disposable micro tissue culture plates for antiviral and interferon induction studies. Appl Microbiol (1971) 2.85
Longitudinal studies of Aedes aegypti (Diptera: Culicidae) in Thailand and Puerto Rico: population dynamics. J Med Entomol (2000) 2.58
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection. Antimicrob Agents Chemother (1998) 2.44
Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother (1998) 2.19
Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Infect Dis (1991) 2.15
Reducing costs and operational constraints of dengue vector control by targeting productive breeding places: a multi-country non-inferiority cluster randomized trial. Trop Med Int Health (2009) 1.91
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrob Agents Chemother (2001) 1.89
Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice. Antimicrob Agents Chemother (1973) 1.87
In vivo antiviral properties of biologically active compounds. II. Studies with influenza and vaccinia viruses. Appl Microbiol (1968) 1.76
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. Antiviral Res (1998) 1.75
Quantitative studies on fabrics as disseminators of viruses. I. Persistence of vaccinia virus on cotton and wool fabrics. Appl Microbiol (1966) 1.72
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201. Antimicrob Agents Chemother (2001) 1.62
Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob Agents Chemother (1999) 1.57
Quantitative studies on fabrics as disseminators of viruses. II. Persistence of poliomyelitis virus on cotton and wool fabrics. Appl Microbiol (1966) 1.55
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Antiviral Res (2001) 1.50
Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus. J Virol (1993) 1.46
Cloning differentially expressed mRNAs. Nat Biotechnol (1996) 1.44
Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir. Antivir Chem Chemother (2001) 1.43
Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals. Antimicrob Agents Chemother (1973) 1.42
The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology (1997) 1.40
Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc Natl Acad Sci U S A (1995) 1.37
Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry (1999) 1.35
Target-organ treatment of neurotropic virus diseases: efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine. Antimicrob Agents Chemother (1972) 1.32
Aedes aegypti (Diptera: Culicidae) movement influenced by availability of oviposition sites. J Med Entomol (1998) 1.32
Receptor tyrosine kinases and the regulation of macrophage activation. J Leukoc Biol (2004) 1.31
Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir. Antiviral Res (2000) 1.30
Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse (2005) 1.26
In vitro and in vivo influenza virus-inhibitory effects of viramidine. Antiviral Res (2005) 1.25
Effect of selenazofurin on influenza A and B virus infections of mice. Antiviral Res (1986) 1.25
Linkage disequilibrium structure and its impact on the localization of a candidate functional mutation. Genet Epidemiol (2001) 1.24
Immune-associated nucleotide-1 (IAN-1) is a thymic selection marker and defines a novel gene family conserved in plants. J Immunol (1999) 1.21
Coordinate expression of ribosomal protein genes during Xenopus development. Dev Biol (1985) 1.19
Influenza virus resistance to neuraminidase inhibitors. Drug Resist Updat (1998) 1.16
Ribavirin: an antiviral agent. Pharmacol Ther (1979) 1.16
Inhibition of RNA virus replication in vitro by 3-deazacytidine and 3-deazauridine. Proc Soc Exp Biol Med (1972) 1.16
The synthesis and SAR of rhodanines as novel class C beta-lactamase inhibitors. Bioorg Med Chem Lett (2000) 1.16
Purine analogs as potential anticytomegalovirus agents. Proc Soc Exp Biol Med (1969) 1.15
Procedure for the evaluation of the virucidal effectiveness of an ethylene oxide gas sterilizer. Appl Microbiol (1969) 1.14
Proteolytic activity of human cytomegalovirus UL80 protease cleavage site mutants. J Virol (1994) 1.14
Quantitative studies on fabrics as disseminators of viruses. 3. Persistence of vaccinia virus on fabrics impregnated with a virucidal agent. Appl Microbiol (1967) 1.13
Effect of ribavirin on viral hepatitis in laboratory animals. Ann N Y Acad Sci (1977) 1.07
Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine. Antimicrob Agents Chemother (1992) 1.07
In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity. Antimicrob Agents Chemother (2004) 1.05
Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen. Antiviral Res (1993) 1.05
Quantitative studies on fabrics as disseminators of viruses. V. Effect of laundering on poliovirus-contaminated fabrics. Appl Microbiol (1971) 1.05
Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity. Antimicrob Agents Chemother (1982) 1.01
Potentially infectious agents associated with shearling bedpads. I. Effect of laundering with detergent-disinfectant combinations on polio and vaccinia viruses. Appl Microbiol (1970) 1.01
Efficacy of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate in therapy of equine abortion virus-induced hepatitis in hamsters. Antimicrob Agents Chemother (1975) 1.01
Structure of the primordial diaphragm and defects associated with nitrofen-induced CDH. J Appl Physiol (1985) (2000) 1.00
Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. J Protozool (1992) 1.00
Antiviral activity of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid. Antimicrob Agents Chemother (1977) 1.00
Antiviral mechanisms of action. Annu Rev Pharmacol Toxicol (1980) 0.99
Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters. Antimicrob Agents Chemother (Bethesda) (1968) 0.99
Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry (2002) 0.99
Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor, in a lethal murine model of influenza predicts efficacy for once-daily dosing. Antimicrob Agents Chemother (2001) 0.99
Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine. J Med Chem (1975) 0.99
Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. Antiviral Res (1999) 0.99
Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir. Antivir Chem Chemother (2000) 0.98
Antiviral activity of 9-beta-D-arabinofuranosyladenine. V. Activity against intracerebral Vaccinia virus infections in mice. Antimicrob Agents Chemother (Bethesda) (1968) 0.98
Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice. J Infect Dis (1976) 0.98
Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides. J Med Chem (1973) 0.98
Heterocyclic thiosemicarbazones: correlation between structure, inhibition of ribonucleotide reductase, and inhibition of DNA viruses. Proc Soc Exp Biol Med (1970) 0.97
Larval microhabitats of Lutzomyia longipalpis (Diptera: Psychodidae) in an endemic focus of visceral leishmaniasis in Colombia. J Med Entomol (1997) 0.96
Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J Neurovirol (1996) 0.95
Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Antivir Ther (1998) 0.95
Bioassay system for determining ribavirin levels in human serum and urine. Chemotherapy (1981) 0.95
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus. Antiviral Res (1995) 0.94
Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. Antiviral Res (1992) 0.94
Anti-DNA virus activity of the 5'-nucleotide and 3',5'-cyclic nucleotide of 9-beta-D-arabinofuranosyladenine. Chemotherapy (1973) 0.93
Selective inhibition of cytomegaloviruses by 9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)g uanine. Antiviral Res (1993) 0.93
Studies of latent Q fever infections. 3. Effects of parturition upon latently infected guinea pigs and white mice. Am J Epidemiol (1966) 0.93
Herpes simplex keratitis in hamsters as a system for evaluating potential antiviral agents. Antimicrob Agents Chemother (Bethesda) (1966) 0.93
In vivo anti-influenza virus activity of a zinc finger peptide. Antimicrob Agents Chemother (1997) 0.93
Mode of inhibition of respiratory syncytial virus by a plant flavonoid, SP-303. Chemotherapy (1993) 0.92
Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues. Antivir Chem Chemother (2001) 0.92
Synthesis and antiviral and enzymatic studies of certain 3-deazaguanines and their imidazolecarboxamide precursors. J Med Chem (1978) 0.92
In vitro studies on the antiviral activity of 1, 3-bis(2-chloroethyl)-1-nitrosourea. Appl Microbiol (1966) 0.91
In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol (1991) 0.91
Azapurine nucleosides. 2. Synthesis and antiviral activity of 7-amino-3- -D-arabinofuranosyl-v-triazolo (4,5-d)pyrimidine and related nucleosides. J Med Chem (1972) 0.91
Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances. Antimicrob Agents Chemother (1981) 0.90
Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on Friend leukemia virus infections in mice. Proc Soc Exp Biol Med (1975) 0.90
Synthesis and antiviral activity of certain thiazole C-nucleosides. J Med Chem (1977) 0.90
Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice. Antiviral Res (1991) 0.89
Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes. Antiviral Res (1997) 0.89
Role of virucides in controlling virus dissemination by fabrics. J Am Oil Chem Soc (1969) 0.88
Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment. J Infect Dis (1991) 0.88
In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin. Chemotherapy (1996) 0.88
Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin). J Med Chem (1978) 0.87